Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. TOT BIOPHARM International Company Limited
  6. Company
    1875   HK0000545266

TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

(1875)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
TOT BIOPHARM International Company Limited is a company mainly engaged in the development and commercialization of oncology drugs and therapies. The Company has a portfolio of oncology drug candidates, which include monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), oncolytic virus products and specialty oncology drugs such as liposome drugs.

Number of employees : 366 people.
Sales per Business
20192020Delta
Self-developed Biological Drug51.38100%25.27100% -50.81%
HKD in Million
Sales per region
20192020Delta
China51.38100%25.27100% -50.81%
HKD in Million
Managers
Name Title Age Since
Jun Liu, Dr. CEO, Executive Director & Chief Scientific Officer 53 2020
Ming Liu Chief Medical Officer & Vice General Manager 60 2017
Lan Hu Independent Non-Executive Director 50 2019
Lijun Sun, Dr. Independent Non-Executive Director 58 2019
Hong Jen Chang, Dr. Independent Non-Executive Director 65 2019
Jau-Chang Yao Co-Secretary & Vice General Manager 51 2018
Wing Yat Lui Joint Secretary 32 2019
Chun-Ming Lin Senior Director-Sales & Marketing 47 2018
Donglian Liu Vice General Manager 52 2016
Xiaobao Chen Senior Director-Chemical Drug Business 39 2016
Members of the board
Name Title Age Since
Shan Fu Non-Executive Chairman 54 2018
Chun Ying Hsiao Executive Director & General Manager 62 2019
Jun Liu, Dr. CEO, Executive Director & Chief Scientific Officer 53 2020
Frank C. Kung, Dr. Non-Executive Director 72 2016
Kang Pei Non-Executive Director 62 2011
Yu Min Qiu Non-Executive Director 48 2018
Lan Hu Independent Non-Executive Director 50 2019
Lijun Sun, Dr. Independent Non-Executive Director 58 2019
Hong Jen Chang, Dr. Independent Non-Executive Director 65 2019
Chun-Ying Yeh-Huang Vice Chairman 62 2020
Shareholders
NameEquities%
Center Laboratories, Inc. 179,561,700 29.2%
Vivo Capital LLC 103,245,000 16.8%
Chengwei Capital Co. Ltd. 56,573,500 9.20%
Advantech Advisors (HK) Limited 49,136,800 7.99%
Chun-Ying Yeh-Huang 11,175,583 1.82%
Jun Liu 3,841,609 0.62%
Company contact information
TOT BIOPHARM International Co. Ltd.
No.120 Changyang Street
Suzhou Industrial Park
Suzhou, Jiangsu

Web : http://www.totbiopharm.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of TOT BIOPHARM International Company Limited